BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21613209)

  • 1. Purification and identification of activating enzymes of CS-0777, a selective sphingosine 1-phosphate receptor 1 modulator, in erythrocytes.
    Yonesu K; Kubota K; Tamura M; Inaba S; Honda T; Yahara C; Watanabe N; Matsuoka T; Nara F
    J Biol Chem; 2011 Jul; 286(28):24765-75. PubMed ID: 21613209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic kinetics regarding reversible metabolism of CS-0777, a sphingosine 1-phosphate receptor modulator, via phosphorylation and dephosphorylation in humans.
    Inaba SI; Yamaguchi-Goto M; Tanaka-Takanaka K; Yonesu K; Sakurai H; Kubota K; Izumi T
    Xenobiotica; 2018 Mar; 48(3):258-268. PubMed ID: 28287856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructosamine 3-kinase-related protein and deglycation in human erythrocytes.
    Collard F; Wiame E; Bergans N; Fortpied J; Vertommen D; Vanstapel F; Delpierre G; Van Schaftingen E
    Biochem J; 2004 Aug; 382(Pt 1):137-43. PubMed ID: 15137908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.
    Delpierrre G; Vertommen D; Communi D; Rider MH; Van Schaftingen E
    J Biol Chem; 2004 Jun; 279(26):27613-20. PubMed ID: 15102834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.
    Collard F; Delpierre G; Stroobant V; Matthijs G; Van Schaftingen E
    Diabetes; 2003 Dec; 52(12):2888-95. PubMed ID: 14633848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein.
    Delplanque J; Delpierre G; Opperdoes FR; Van Schaftingen E
    J Biol Chem; 2004 Nov; 279(45):46606-13. PubMed ID: 15331600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
    Brinkmann V
    Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
    Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
    J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4.
    Ohotski J; Rosen H; Bittman R; Pyne S; Pyne NJ
    Cell Signal; 2014 May; 26(5):1040-7. PubMed ID: 24486401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme.
    Fortpied J; Gemayel R; Stroobant V; van Schaftingen E
    Biochem J; 2005 Jun; 388(Pt 3):795-802. PubMed ID: 15705060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes.
    Hellwig A; Scherber A; Koehler C; Hanefeld M; Henle T
    Clin Chem Lab Med; 2014 Jan; 52(1):93-101. PubMed ID: 23648633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of a synthetic fructosamine into its 3-phospho derivative in human erythrocytes.
    Delpierre G; Vanstapel F; Stroobant V; Van Schaftingen E
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):835-9. PubMed ID: 11104693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
    Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
    Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructosamine-3-kinase-related-protein phosphorylates glucitolamines on the C-4 hydroxyl: novel substrate specificity of an enigmatic enzyme.
    Szwergold B; Manevich Y; Payne L; Loomes K
    Biochem Biophys Res Commun; 2007 Oct; 361(4):870-5. PubMed ID: 17686456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients.
    Moberly JB; Ford DM; Zahir H; Chen S; Mochizuki T; Truitt KE; Vollmer TL
    J Neuroimmunol; 2012 May; 246(1-2):100-7. PubMed ID: 22465063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J; Lana D; Round O; LaMontagne K
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells.
    Lan T; Liu W; Xie X; Xu S; Huang K; Peng J; Shen X; Liu P; Wang L; Xia P; Huang H
    Mol Endocrinol; 2011 Dec; 25(12):2094-105. PubMed ID: 21998146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.
    Allende ML; Sasaki T; Kawai H; Olivera A; Mi Y; van Echten-Deckert G; Hajdu R; Rosenbach M; Keohane CA; Mandala S; Spiegel S; Proia RL
    J Biol Chem; 2004 Dec; 279(50):52487-92. PubMed ID: 15459201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases.
    Billich A; Bornancin F; Dévay P; Mechtcheriakova D; Urtz N; Baumruker T
    J Biol Chem; 2003 Nov; 278(48):47408-15. PubMed ID: 13129923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.